An observational study in Atmospheric Pressure; Adverse Effect and Epistaxis Nosebleed, sponsored by Saglik Bilimleri Universitesi. Recruiting at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-01.
Sponsored by Saglik Bilimleri Universitesi · Observational
In this study, investigators aim to understand the relationship between changes in atmospheric pressure and blood pressure, and to investigate whether these changes have an impact on the etiology of epistaxis.
This study aims to investigate the potential effects of changes in atmospheric pressure on epistaxis and, if such effects exist, to review treatment adjustments based on weather forecasts for hypertensive patients to prevent potential hypertensive emergencies and enhance patient comfort. This research poses no risk to patients and is purely observational and clinical in nature.
The study will be conducted prospectively over a period of 6 months at the Emergency Department of Ankara Etlik City Hospital, focusing on patients presenting with epistaxis.After initial evaluation upon presentation to the emergency department, patients will undergo routine emergency department monitoring for epistaxis, including physical examination, vital sign monitoring, evaluation of coagulation parameters, and hemoglobin levels. Apart from routine tests, no additional invasive or non-invasive procedures will be performed by us.
Data obtained from patients and daily atmospheric pressure parameters will be evaluated and analyzed.
96 studies on the registry are indexed under Epistaxis; 22 are open to participants now.
This study's planned enrollment of 600 is above the median of 71 across 12 observational studies indexed under Epistaxis.
Browse Epistaxis studies →Saglik Bilimleri Universitesi is the lead sponsor of 453 studies on the registry; 140 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients over the age of 18 presenting to emergency department with epistaxis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients aged 18 and above Presenting to the emergency department with complaints of epistaxis, whether active or resolved.
Willing volunteers consenting to participate in the study. Residing in central districts of Ankara
Exclusion Criteria:
Patients under the age of 18. Pregnant individuals. Those with a history of maxillofacial surgery. Patients reporting a history of trauma at the time of admission. Patients stating they are from a city other than Ankara.
patients presenting to emergency department with epistaxis
epistaxis
number of the patients with epistaxis will be evaluated accoridng to atmospheric preesure and wheather conditions on daily basis
Time frame: 24 hours
Plan to share: No
Started Apr 2024 (actual). Primary completion is estimated for Apr 2025, 12 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Saglik Bilimleri Universitesi →